VEGFA and lung carcinoma: In lung cancer cells, inhibition of MMP2 activity reduces its interaction with integrin-AVB3, and inhibits the expression of VEGF mediated by downstream PI3K/AKT signaling, leading to decreased angiogenesis (32).